medication adherence

Replacing the frequent home visits often necessary for tuberculosis treatment with video visits facilitated by an app appears to be a cost-effective, well-received means of ensuring adherence throughout therapy, according to a recently published pilot study.

Following a successful nine-month pilot, Boehringer Ingelheim and HealthPrize Technologies announced that the digital adherence support program RespiPoints will be expanded to any patient who is taking certain Boehringer Ingelheim medications, including some available in the Respimat inhaler.

Cambridge, Massachusetts-based Common Sensing, which specializes in connected containers for injectable medications, has raised $6.

Medication management app maker Medisafe has a guiding principle when it comes to the difficult task of improving medication adherence: One size does not fit all.

A new large-scale study shows that interactive, tailored text messages can improve medication adherence by 14 percent.

Mount Sinai Health System is trying a new way to get high-risk patients to take their medications: financial incentives.

UK-based Babylon, a remote care company, has raised $25 million in a round led by Investment AB Kinnevik with participation from Hoxton Ventures, Innocent Drinks cofounders Richard Reed, Adam Balon, and Jon Wright, as well as Deepmind cofounders Demis Hassabis and Mustafa Suleyman.

There are many approaches to using digital technology to promote medication adherence, from tiny sensors embedded in pills to Bluetooth-connected pill boxes, to simple reminder apps.

Google has filed another interesting healthcare-related patent, a mechanism that could detect when a patient is eating and issue a contextual reminder to take a medication.

Redwood City, California-based Proteus Digital Health announced its first US healthcare provider customer, Barton Health, which will prescribe the company's Proteus Discover to patients.